NT5DC4
gene geneOn this page
Summary
NT5DC4 (5’-nucleotidase domain containing 4, HGNC:27678) is a protein-coding gene on chromosome 2q14.1, encoding 5’-nucleotidase domain-containing protein 4 (Q86YG4).
Predicted to enable 5’-nucleotidase activity.
Source: NCBI Gene 284958 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 5 total
- MANE Select transcript:
NM_001393655
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:27678 |
| Approved symbol | NT5DC4 |
| Name | 5’-nucleotidase domain containing 4 |
| Location | 2q14.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000144130 |
| Ensembl biotype | protein_coding |
| Entrez | 284958 |
Gene structure
Transcript identifiers
Ensembl transcripts: 9 — 4 protein_coding, 3 retained_intron, 2 protein_coding_CDS_not_defined
ENST00000327581, ENST00000462854, ENST00000470675, ENST00000484666, ENST00000491170, ENST00000497526, ENST00000688554, ENST00000689550, ENST00000690591
RefSeq mRNA: 2 — MANE Select: NM_001393655
NM_001350494, NM_001393655
CCDS: CCDS86877, CCDS92846
Canonical transcript exons
ENST00000688554 — 17 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000963719 | 112722183 | 112722278 |
| ENSE00000963721 | 112722714 | 112722771 |
| ENSE00001000617 | 112725174 | 112725240 |
| ENSE00001246213 | 112723081 | 112723174 |
| ENSE00001332648 | 112724094 | 112724126 |
| ENSE00003477029 | 112726238 | 112726289 |
| ENSE00003516346 | 112725382 | 112725552 |
| ENSE00003526039 | 112723418 | 112723468 |
| ENSE00003526420 | 112726678 | 112726738 |
| ENSE00003535058 | 112721986 | 112722103 |
| ENSE00003549565 | 112721818 | 112721891 |
| ENSE00003565602 | 112729627 | 112729704 |
| ENSE00003684205 | 112723719 | 112723802 |
| ENSE00003928650 | 112724781 | 112724906 |
| ENSE00003930278 | 112738913 | 112739095 |
| ENSE00003934116 | 112721020 | 112721153 |
| ENSE00003934954 | 112722483 | 112722589 |
Expression profiles
Bgee: expression breadth ubiquitous, 129 present calls, max score 83.69.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.3710 / max 97.1539, expressed in 94 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 22012 | 0.2364 | 59 |
| 22011 | 0.0870 | 32 |
| 22013 | 0.0477 | 21 |
Top tissues by expression
235 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 83.69 | gold quality |
| left testis | UBERON:0004533 | 81.31 | gold quality |
| right testis | UBERON:0004534 | 80.79 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 80.40 | gold quality |
| testis | UBERON:0000473 | 77.06 | gold quality |
| sperm | CL:0000019 | 76.59 | gold quality |
| buccal mucosa cell | CL:0002336 | 67.33 | gold quality |
| vermiform appendix | UBERON:0001154 | 66.44 | gold quality |
| spleen | UBERON:0002106 | 66.24 | gold quality |
| blood | UBERON:0000178 | 66.14 | gold quality |
| ventricular zone | UBERON:0003053 | 64.06 | gold quality |
| monocyte | CL:0000576 | 63.02 | gold quality |
| leukocyte | CL:0000738 | 62.28 | gold quality |
| granulocyte | CL:0000094 | 62.20 | gold quality |
| right lung | UBERON:0002167 | 61.80 | gold quality |
| lymph node | UBERON:0000029 | 61.60 | gold quality |
| caecum | UBERON:0001153 | 60.76 | gold quality |
| ganglionic eminence | UBERON:0004023 | 56.73 | gold quality |
| right uterine tube | UBERON:0001302 | 56.54 | gold quality |
| lower lobe of lung | UBERON:0008949 | 56.47 | silver quality |
| colonic epithelium | UBERON:0000397 | 56.39 | silver quality |
| upper lobe of lung | UBERON:0008948 | 54.49 | gold quality |
| upper lobe of left lung | UBERON:0008952 | 54.33 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 51.34 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 49.87 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 49.15 | gold quality |
| lung | UBERON:0002048 | 48.67 | gold quality |
| small intestine | UBERON:0002108 | 48.13 | gold quality |
| rectum | UBERON:0001052 | 46.81 | gold quality |
| duodenum | UBERON:0002114 | 46.16 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 2.26 |
Regulation
Is transcription factor: no
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | nt5c2l1 | ENSDARG00000034852 |
| drosophila_melanogaster | Nt5c | FBGN0033426 |
| drosophila_melanogaster | Nt5b | FBGN0052549 |
| caenorhabditis_elegans | WBGENE00022201 |
Paralogs (4): NT5C2 (ENSG00000076685), NT5DC3 (ENSG00000111696), NT5DC2 (ENSG00000168268), NT5DC1 (ENSG00000178425)
Protein
Protein identifiers
5’-nucleotidase domain-containing protein 4 — Q86YG4 (reviewed: Q86YG4)
All UniProt accessions (3): Q86YG4, A0A8I5KQP2, A0A8I5KQQ4
UniProt curated annotations — full annotation on UniProt →
Miscellaneous. Gene prediction based on conservation.
Similarity. Belongs to the 5’(3’)-deoxyribonucleotidase family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q86YG4-1 | 1 | yes |
| Q86YG4-2 | 2 |
RefSeq proteins (2): NP_001337423, NP_001380584* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR008380 | HAD-SF_hydro_IG_5-nucl | Family |
| IPR016695 | Pur_nucleotidase | Family |
| IPR023214 | HAD_sf | Homologous_superfamily |
| IPR036412 | HAD-like_sf | Homologous_superfamily |
Pfam: PF05761
UniProt features (11 total): splice variant 4, binding site 3, active site 2, chain 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q86YG4-F1 | 87.66 | 0.76 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Catalytic / active sites (2): 22 (nucleophile); 24 (proton donor)
Ligand- & substrate-binding residues (3): 22; 24; 317
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 33 (showing top):
GOBP_ORGANOPHOSPHATE_METABOLIC_PROCESS, GOBP_CARBOHYDRATE_DERIVATIVE_METABOLIC_PROCESS, GOBP_NUCLEOBASE_CONTAINING_SMALL_MOLECULE_METABOLIC_PROCESS, GOBP_NUCLEOSIDE_MONOPHOSPHATE_METABOLIC_PROCESS, GOBP_GMP_METABOLIC_PROCESS, GOBP_PURINE_CONTAINING_COMPOUND_METABOLIC_PROCESS, chr2q14, GOMF_HYDROLASE_ACTIVITY_ACTING_ON_ESTER_BONDS, GOMF_NUCLEOTIDASE_ACTIVITY, GOMF_PHOSPHORIC_ESTER_HYDROLASE_ACTIVITY, GOBP_PURINE_NUCLEOSIDE_MONOPHOSPHATE_METABOLIC_PROCESS, GOMF_PHOSPHATASE_ACTIVITY, GOBP_PURINE_DEOXYRIBONUCLEOTIDE_METABOLIC_PROCESS, CBX7_TARGET_GENES, NME2_TARGET_GENES
GO Biological Process (2): GMP metabolic process (GO:0046037), dGMP metabolic process (GO:0046054)
GO Molecular Function (3): 5’-nucleotidase activity (GO:0008253), metal ion binding (GO:0046872), hydrolase activity (GO:0016787)
GO Cellular Component (0):
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| purine ribonucleotide metabolic process | 1 |
| purine ribonucleoside monophosphate metabolic process | 1 |
| purine deoxyribonucleotide metabolic process | 1 |
| purine deoxyribonucleoside monophosphate metabolic process | 1 |
| nucleotidase activity | 1 |
| cation binding | 1 |
| catalytic activity | 1 |
Protein interactions and networks
STRING
328 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| NT5DC4 | NT5DC1 | Q5TFE4 | 412 |
| NT5DC4 | APOL5 | Q9BWW9 | 393 |
| NT5DC4 | HERPUD2 | Q9BSE4 | 377 |
| NT5DC4 | CYB561A3 | Q8NBI2 | 376 |
| NT5DC4 | CDC14C | A4D256 | 373 |
| NT5DC4 | CHCHD5 | Q9BSY4 | 370 |
| NT5DC4 | XPNPEP2 | O43895 | 358 |
| NT5DC4 | ACY3 | Q96HD9 | 322 |
| NT5DC4 | B3GNT7 | Q8NFL0 | 315 |
| NT5DC4 | ADSS1 | Q8N142 | 314 |
| NT5DC4 | CKAP2L | Q8IYA6 | 305 |
| NT5DC4 | ELP2 | Q6IA86 | 305 |
| NT5DC4 | WBP1L | Q9NX94 | 297 |
| NT5DC4 | TIAM2 | Q8IVF5 | 284 |
| NT5DC4 | APOO | Q9BUR5 | 271 |
IntAct
2 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| CUL5 | DDX3X | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (3): NT5DC4 (Affinity Capture-MS), NT5DC4 (Affinity Capture-RNA), NT5DC4 (Affinity Capture-MS)
ESM2 similar proteins: A1E9I4, A1E9R7, A1EA01, A2T321, A4GGA8, A4GYP7, A4QJA4, A4QK94, A4QL95, A6H5F6, A6MMJ6, A7M8Z3, A7M955, A8W3B3, A8W3H9, A8Y9G3, A9L985, A9QC56, B0YPM1, B0Z4M8, B0Z4W2, B0Z5D0, B1NWD9, P06354, P08242, P0C480, P0C481, P0C482, P16037, P17933, P27068, P41605, Q06FX2, Q06RE2, Q14FG8, Q32RY1, Q3BAQ3, Q4FG66, Q4VZP4, Q5SCY1
Diamond homologs: A4IHT9, Q3UHB1, Q54XC1, Q5TFE4, Q6GN91, Q6Q0N3, Q75K12, Q86UY8, Q86YG4, Q9H857, D3ZMY7, O46411, P49902, Q3V1L4, Q5EBF1, Q5RA22, Q5ZIZ4, Q6DKB0, Q2TBU5, Q8C5P5
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
5 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 1 |
| Likely benign | 3 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
3511 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 2:112722102:AGGTG:A | donor_loss | 1.0000 |
| 2:112722104:G:GA | donor_loss | 1.0000 |
| 2:112722105:T:G | donor_loss | 1.0000 |
| 2:112722276:GGA:G | donor_gain | 1.0000 |
| 2:112722277:GA:G | donor_gain | 1.0000 |
| 2:112722277:GAG:G | donor_gain | 1.0000 |
| 2:112722279:G:GG | donor_gain | 1.0000 |
| 2:112722768:C:CG | donor_gain | 1.0000 |
| 2:112722772:G:GG | donor_gain | 1.0000 |
| 2:112722808:G:GG | donor_gain | 1.0000 |
| 2:112722824:G:GT | donor_gain | 1.0000 |
| 2:112722825:G:T | donor_gain | 1.0000 |
| 2:112723069:T:A | acceptor_gain | 1.0000 |
| 2:112723073:T:TA | acceptor_gain | 1.0000 |
| 2:112723077:CCA:C | acceptor_loss | 1.0000 |
| 2:112723079:A:AG | acceptor_gain | 1.0000 |
| 2:112723079:AGTT:A | acceptor_gain | 1.0000 |
| 2:112723080:G:GG | acceptor_gain | 1.0000 |
| 2:112723080:GT:G | acceptor_gain | 1.0000 |
| 2:112723080:GTT:G | acceptor_gain | 1.0000 |
| 2:112723080:GTTG:G | acceptor_gain | 1.0000 |
| 2:112723080:GTTGT:G | acceptor_gain | 1.0000 |
| 2:112723171:GTCG:G | donor_gain | 1.0000 |
| 2:112723173:CGGTG:C | donor_loss | 1.0000 |
| 2:112723175:GTGA:G | donor_gain | 1.0000 |
| 2:112723177:GA:G | donor_gain | 1.0000 |
| 2:112723179:G:GG | donor_gain | 1.0000 |
| 2:112723718:GCCAC:G | acceptor_gain | 1.0000 |
| 2:112723798:CCAAT:C | donor_gain | 1.0000 |
| 2:112723801:AT:A | donor_gain | 1.0000 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000099265 (2:112729739 G>A), RS1000155036 (2:112726133 C>T), RS1000165157 (2:112728542 A>G), RS1000209677 (2:112730513 A>C,G), RS1000240737 (2:112730205 C>T), RS1000389830 (2:112725062 C>T), RS1000390570 (2:112742568 T>C), RS1000456706 (2:112725166 C>T), RS1000509832 (2:112731647 T>C), RS1000547170 (2:112729353 C>A,G,T), RS1000614013 (2:112725940 G>A), RS1000726696 (2:112726172 G>C), RS1000815046 (2:112720188 T>A,G), RS1000829518 (2:112736313 T>C), RS1001130692 (2:112735472 T>C)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST90002407_60 | White blood cell count | 4.000000e-11 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
15 total (human), top 15 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| OTX015 | decreases expression | 1 |
| 3,4-dichloroaniline | increases expression | 1 |
| beta-lapachone | increases expression | 1 |
| sodium arsenite | decreases expression | 1 |
| ferrous chloride | increases expression | 1 |
| abrine | increases expression | 1 |
| (+)-JQ1 compound | decreases expression | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Diuron | increases expression | 1 |
| Formaldehyde | increases expression | 1 |
| Methyl Methanesulfonate | increases expression | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
| Silicon Dioxide | decreases expression | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Tretinoin | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.